Episode 5: Psychedelics 2.0: What will the future hold? - a podcast by Zeifmans LLP
from 2020-09-02T16:00
On today's episode of Micro-dosing with Zeifmans, we discuss "what's next" for the psychedelics industry. Join our host, Larry Zeifman and this week's guests, Ronan Levy, Founder and Executive of Field Trip Health, and Susan Chapelle, Co-CEO of Havn Life, for Episode 5: Psychedelics 2.0.
Have questions or want to learn more? Contact us direct at info@zeifmans.ca.
Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.
At Field Trip, we are redefining mental health and well-being through ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy. With Field Trip Health centres opening across North America, and drug development and advanced research on plant-based psychedelics through Field Trip Discovery, we help people to heal and heighten engagement with the world.
Using a foundation of evidence-informed research Havn wants to empower people to connect to their potential and thrive. Havn is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products. Havn Labs, a division of Havn, will support innovative therapies addressing human health through the development of methods for standardization and the extraction of quality-controlled compounds derived from plants and fungi.
Further episodes of Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics
Further podcasts by Zeifmans LLP
Website of Zeifmans LLP